Document is current
Any future updates will be listed below
-
Authors
Kasper, Siegfried https://orcid.org/0000-0001-8278-191X
Eckert, Anne
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 13 July 2024
Accepted: 31 August 2024
First Online: 25 October 2024
Declarations
:
: Not applicable since it is a review of published data.
: In the past 3 years Siegfried Kasper served as a <b>consultant or on advisory boards</b> for Angelini, Biogen, Boehringer, Esai, Janssen, IQVIA, Mylan, Recordati, Rovi, Sage and Schwabe; and he has served <b>on speakers bureaus</b> for Angelini, Aspen Farmaceutica S.A., Biogen, Janssen, Recordati, Schwabe, Servier, Sothema, and Sun Pharma. Anne Eckert received grant support from Schwabe and OM Pharma, served as a consultant on advisory boards for Schwabe and OM Pharma.
